GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES ANG, ANGPT1, VEGFA, FGF1, HIF1Α, HGF, SDF1, KLK4, PDGFC, PROK1, PROK2 TO INCREASE EXPRESSION LEVEL OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-ANG, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-ANGPT1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-VEGFA, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-FGF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HIF1Α, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SDF1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KLK4, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PDGFC, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-PROK2, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR Russian patent published in 2020 - IPC C12N15/12 C12N15/70 C12N1/21 A61K48/00 C12R1/19 

Abstract RU 2730664 C2

FIELD: biotechnology; medicine; agriculture.

SUBSTANCE: invention refers to genetic engineering and can be used in biotechnology, medicine and agriculture to develop gene therapy preparations. Disclosed is a genotyping DNA vector based on the VTvaf17 gene-vector DNA vector carrying a target gene selected from a group of genes ANG, ANGPT1, VEGFA, FGF1, HIF1α, HGF, SDF1, KLK4, PDGFC, PROK1, PROK2, to increase level of expression of this target gene in human body and animals. Gene therapy DNA vector VTvaf17-ANG, or VTvaf17-ANGPT1, or VTvaf17-VEGFA, or VTvaf17-FGF1, or VTvaf17-HIF1α, or VTvaf17-HGF, or VTvaf17-SDF1, or VTvaf17-KLK4, or VTvaf17-PDGFC, or VTvaf17-PROK1, or VTvaf17-PROK2 has a nucleotide sequence SEQ ID No. 1, or SEQ ID No. 2, or SEQ ID No. 3, or SEQ ID No. 4, or SEQ ID No. 5, or SEQ ID No. 6, or SEQ ID No. 7, or SEQ ID No. 8, or SEQ ID No. 9, or SEQ ID No. 10, or SEQ ID No. 11, respectively. Disclosed are method of producing said vector, using a vector to increase the level of expression of target genes, an Escherichia coli strain carrying said vector, as well as a method for production of said vector on an industrial scale.

EFFECT: invention provides the possibility of its safe application for genetic therapy of humans and animals.

28 cl, 29 dwg, 41 ex

Similar patents RU2730664C2

Title Year Author Number
GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING THE TARGET GENE SELECTED FROM A GROUP OF GENES BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, IGF1, TO INCREASE EXPRESSION LEVEL OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, A STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-BDNF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-VEGFA, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-BFGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-GDNF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NT3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CNTF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-IGF1, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2732479C2
GENE THERAPY DNA-VECTOR BASED ON GENE THERAPY DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF IFNB1, IFNA14, IFNA2, IL12A, IL12B GENES TO INCREASE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PREPARATION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-IFNB1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-IFNA14, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-IFNA2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-IL12A, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-IL12B, CARRYING GENE-THERAPEUTIC DNA-VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE THERAPY DNA VECTOR 2018
  • Savelieva Natalia
RU2720519C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES COL1A1, COL1A2, P4HA1, P4HA2, COL7A1, CLCA2, ELN, PLOD1 TO INCREASE LEVEL OF EXPRESSION OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-COL1A1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL1A2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-P4HA1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-P4HA2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL7A1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CLCA2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-ELN, OR ESCHERICHIA COLI SCS110-AF/VTVAF17- PLOD1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2730661C2
GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTvaf17, CARRYING THE TARGET GENE SELECTED FROM THE GROUP OF GENES COL1A1, COL1A2, BMP2, BMP7, TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, ESCHERICHIA COLI SCS110-AF/VTvaf17-COL1A1 STRAIN OR ESCHERICHIA COLI SCS110-AF/VTvaf17-COL1A2 OR ESCHERICHIA COLI SCS110-AF/VTvaf17-BMP2 OR ESCHERICHIA COLI SCS110-AF/VTvaf17-BMP7, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA-VECTOR 2018
  • Savelieva Natalia
  • Lazarev Vasilij Nikolaevich
  • Shmarina Galina Vasilevna
RU2707537C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING THE TARGET GENE SELECTED FROM THE SOD1, SOD2, SOD3, CAT GENE GROUP TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD1 STRAIN, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CAT, CARRYING A GENE-THERAPEUTIC DNA VECTOR, A METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2731515C2
GENE THERAPY DNA VECTOR BASED ON GENE THERAPY DNA VECTOR VTvaf17 CARRYING A TARGET GENE SELECTED FROM THE GROUP OF OPG, PDGFA, PDGFB GENES TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR ITS PREPARATION AND USE, STRAIN ESCHERICHIA COLI SCS110-AF/VTvaf17-OPG, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-PDGFA, OR ESCHERICHIA COLI SCS110-AF/VTvaf17-PDGFB, CARRYING GENE THERAPY DNA VECTOR, METHOD FOR ITS PRODUCTION, METHOD FOR INDUSTRIAL SCALE PRODUCTION OF GENE THERAPY DNA VECTOR 2018
  • Savelieva Natalia
RU2771961C2
GENE-THERAPY DNA-VECTOR BASED ON GENE-THERAPY DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES IL11, LIF, DICER, HOXA10, WT1, TO INCREASE EXPRESSION LEVEL OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-IL11, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-LIF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-DICER, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-HOXA10, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-WT1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2720376C1
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES NOS2, NOS3, VIP, KCNMA1, CGRP, TO INCREASE EXPRESSION LEVEL OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-NOS2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NOS3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-VIP, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KCNMA1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CGRP, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2731513C2
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES KRT5, KRT14, LAMB3, COL7A1, TO INCREASE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-KRT5, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KRT14, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-LAMB3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL7A1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2730667C2
GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM SHH, CTNNB1, NOG, WNT7A GENE GROUP TO INCREASE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-SHH, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CTNNB1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NOG, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-WNT7A, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR 2018
  • Savelieva Natalia
RU2731514C2

RU 2 730 664 C2

Authors

Savelieva Natalia

Dates

2020-08-24Published

2018-12-27Filed